Autonomous 4-Agent Pipeline
Data packets flow from intake to research, database verification, and hardware compilation
Deterministic Multi-Agent Pipeline Canvas
Decoupled 4-agent state machine transitioning loose conversational prompts into verified hardware uploads.
Agent 1: Pathophysiology Ingestion
Parses primary condition etiology, microangiopathy, and comorbid sequelae.
Agent 2: Frequency DB Matcher
Cross-checks targets against 156 validated Channel A (pathology) & Channel B (tissue) pairs.
Agent 3: Protocol Architect
Sequences 4 therapeutic phases, assigns durations (min), polarity, and 100µA current.
Agent 4: Hardware Code Compiler
Compiles machine-readable code for direct upload into microcurrent software.
Clinical Intake & Research Agent
Psychophysiologist bioelectric research & comorbidity weighting
Role: Clinical Psychophysiologist & Bioelectric Medicine Specialist. 1. Pathophysiology: Estrogen-driven adipocyte hypertrophy -> capillary fenestration breakdown -> interstitial glycosaminoglycan expansion -> hypoxia -> TGF-beta1 fibrosis. 2. Sequelae: Secondary lymphedema due to mechanical compression of initial lymphatics, micro-bruising from vascular fragility, and unremitting neuropathic aching. 3. Psychophysiological Axis: Sympathetic hypertonia, emotional limbic trauma (PTSD somatic imprint), and pituitary-adrenal-thyroid exhaustion. 4. FSM Strategy: Phase 1 Anti-Inflammation (40/97, 40/105, 40/13) -> Phase 2 Cellular Repair (124/97, 14/97, 14/13) -> Phase 3 Fibrosis Dissolution (51/97, 970/97, 13/142) -> Phase 4 Neuro-Endocrine Reboot (970/534, 41/6, 49/3, 321/3, 543/49).
Phased Clinical Protocol Sequence
16 StepsChronologically phased frequency pairings optimized for acute cytokine quenching, tissue repair, and drainage.
| Step | Phase / Stage | Channel A (Pathology) | Channel B (Tissue) | Duration | Current | Wave / Polarity | Clinical Action & Mechanism |
|---|---|---|---|---|---|---|---|
| #01 | Phase 1: Capillary Stabilization & Anti-Inflammatory | 40 HzReduce Inflammation | 97 HzAdipose Tissue | 3 min | 100 µA | Alternating • Biphasic | Adipose Tissue PathologyReduce inflammation in adipose tissue. |
| #02 | Phase 1: Capillary Stabilization & Anti-Inflammatory | 284 HzReduce Chronic Inflammation | 97 HzAdipose Tissue | 3 min | 100 µA | Alternating • Biphasic | Adipose Tissue PathologyReduce chronic inflammation in adipose tissue. |
| #03 | Phase 1: Capillary Stabilization & Anti-Inflammatory | 14 HzReduce Swelling & Edema | 97 HzAdipose Tissue | 3 min | 100 µA | Alternating • Biphasic | Adipose Tissue PathologyReduce swelling and edema within the adipose layer. |
| #04 | Phase 1: Capillary Stabilization & Anti-Inflammatory | 51 HzAddress Fibrotic Changes | 97 HzAdipose Tissue | 3 min | 100 µA | Alternating • Biphasic | Adipose Tissue PathologyAddress fibrotic changes within the adipose tissue. |
| #05 | Phase 1: Capillary Stabilization & Anti-Inflammatory | 13 HzAddress Scar Tissue & Adhesions | 97 HzAdipose Tissue | 3 min | 100 µA | Alternating • Biphasic | Adipose Tissue PathologyAddress scar tissue and adhesions within the adipose tissue. |
| #06 | Phase 1: Capillary Stabilization & Anti-Inflammatory | 124 HzTreat Broken & Torn Structure | 97 HzAdipose Tissue | 3 min | 100 µA | Alternating • Biphasic | Adipose Tissue PathologyTreat the 'broken and torn' structure of the adipose tissue to promote repair. |
| #07 | Phase 1: Capillary Stabilization & Anti-Inflammatory | 58 HzAddress Tissue Degeneration | 97 HzAdipose Tissue | 3 min | 100 µA | Alternating • Biphasic | Adipose Tissue PathologyAddress tissue degeneration and destruction in the adipose layer. |
| #08 | Phase 1: Capillary Stabilization & Anti-Inflammatory | 3 HzTreat Sclerosis & Hardening | 97 HzAdipose Tissue | 3 min | 100 µA | Alternating • Biphasic | Adipose Tissue PathologyTreat sclerosis and hardening within adipose tissue. |
| #09 | Phase 1: Capillary Stabilization & Anti-Inflammatory | 40 HzReduce Inflammation | 105 HzBlood Vessels | 3 min | 100 µA | Alternating • Biphasic | Microvascular FragilityReduce inflammation in the blood vessels. |
| #10 | Phase 1: Capillary Stabilization & Anti-Inflammatory | 284 HzChronic Inflammation | 105 HzBlood Vessels | 3 min | 100 µA | Alternating • Biphasic | Microvascular FragilityAddress chronic inflammation in blood vessels. |
| #11 | Phase 1: Capillary Stabilization & Anti-Inflammatory | 14 HzReduce Swelling & Edema | 105 HzBlood Vessels | 3 min | 100 µA | Alternating • Biphasic | Microvascular FragilityReduce swelling and edema in the blood vessels. |
| #12 | Phase 1: Capillary Stabilization & Anti-Inflammatory | 294 HzNeurological Trauma | 105 HzBlood Vessels | 3 min | 100 µA | Alternating • Biphasic | Microvascular FragilityAddress the neurological trauma component in the blood vessels. |
| #13 | Phase 1: Capillary Stabilization & Anti-Inflammatory | 139 HzCoagulation & Stasis | 79 HzVeins | 3 min | 100 µA | Alternating • Biphasic | Venous StasisAddress coagulation issues, prolapsus, and stasis in the veins. |
| #14 | Phase 1: Capillary Stabilization & Anti-Inflammatory | 14 HzReduce Swelling & Edema | 79 HzVeins | 3 min | 100 µA | Alternating • Biphasic | Venous StasisReduce swelling and edema in the veins. |
| #15 | Phase 1: Capillary Stabilization & Anti-Inflammatory | 40 HzReduce Inflammation | 13 HzLymphatic System | 3 min | 100 µA | Alternating • Biphasic | Lymphatic SequelaeReduce inflammation in the lymphatic system. |
| #16 | Phase 1: Capillary Stabilization & Anti-Inflammatory | 284 HzChronic Inflammation | 13 HzLymphatic System | 3 min | 100 µA | Alternating • Biphasic | Lymphatic SequelaeAddress chronic inflammation in the lymphatic system. |
Device Coding & Google Sheets Compiler
Hardware ReadyMachine-readable specifications for Google Sheets and microcurrent stimulators
Ctrl+V in Google Sheets.Channel A,Channel B,Description 40,97,"Reduce inflammation in adipose tissue." 284,97,"Reduce chronic inflammation in adipose tissue." 14,97,"Reduce swelling and edema within the adipose layer." 51,97,"Address fibrotic changes within the adipose tissue." 13,97,"Address scar tissue and adhesions within the adipose tissue." 124,97,"Treat the 'broken and torn' structure of the adipose tissue to promote repair." 58,97,"Address tissue degeneration and destruction in the adipose layer." 3,97,"Treat sclerosis and hardening within adipose tissue." 40,105,"Reduce inflammation in the blood vessels." 284,105,"Address chronic inflammation in blood vessels." 14,105,"Reduce swelling and edema in the blood vessels." 294,105,"Address the neurological trauma component in the blood vessels." 139,79,"Address coagulation issues, prolapsus, and stasis in the veins." 14,79,"Reduce swelling and edema in the veins." 40,13,"Reduce inflammation in the lymphatic system." 284,13,"Address chronic inflammation in the lymphatic system." 14,13,"Reduce swelling and edema in the lymphatic system." 106,13,"Address pathological discharges and stagnation in the lymphatic system." 40,77,"Reduce inflammation in connective tissue." 284,77,"Address chronic inflammation in connective tissue." 51,77,"Address fibrosis in the connective tissue." 13,77,"Treat scar tissue and adhesions in the connective tissue." 91,77,"Address hardening or induration in the connective tissue." 294,77,"Address the neurological trauma component in the connective tissue." 51,142,"Address fibrosis in the fascia." 13,142,"Treat scar tissue and adhesions in the fascia." 91,97,"Address hardening/induration in the adipose tissue." 40,396,"Reduce inflammation in the peripheral nerves to alleviate neuropathic pain." 29,396,"Relieve nerve spasms." 294,396,"Address the neurological component of past trauma or shock related to the condition." 94,396,"Address the effects of nerve trauma on the peripheral nerves." 970,534,"To address the emotional component of the limbic system." 294,534,"To remove the emotional trauma and PTSD component from the limbic system." 41,6,"To reduce tension in the sympathetic nervous system." 49,3,"To increase vitality and support the parasympathetic nervous system." 321,3,"To reboot the parasympathetic nervous system." 40,109,"To reduce inflammation in the vagus nerve." 23,310,"To restore and support endocrine secretions of the anterior pituitary gland." 23,71,"To support the adrenal cortex in the secretion of hormones like cortisol and aldosterone." 41,315,"To reduce tension in the adrenal medulla." 300,98,"To support the thyroid in the production of thyroxine, a key metabolic hormone." 284,98,"To address chronic inflammation in the thyroid gland." 3,98,"To treat sclerosis or hardening within the thyroid gland." 23,7,"To support endocrine secretions of the ovaries and testes." 51,34,"To address fibroid tumors in the uterus." 59,34,"To address cysts in the uterus." 256,35,"To clear poisons and toxins from the liver." 33,23,"To clear aluminum from the kidneys." 37,23,"To clear aluminum from the kidneys." 68,23,"To clear copper from the kidneys." 543,49,"To enhance vitality and support mitochondrial function." 58,543,"To address tissue degeneration at the mitochondrial level."